We have herein provided evidence that redox-active Mn porphyrin, BMX-001 (MnTnBuOE-2-PyP5+), bears therapeutic potential for reducing chemotherapy-induced peripheral neuropathy at clinically relevant dosing via microglia/TNF-α signaling involved in suppression of neuroinflammation. This evidence concerns the gene TNF and peripheral neuropathy.